Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92726612 | 9272661 | 2 | F | 20130416 | 20160901 | 20130506 | 20160913 | EXP | AT-BAXTER-2013BAX016160 | BAXTER | 42.95 | YR | F | Y | 98.00000 | KG | 20160912 | MD | AT | AT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92726612 | 9272661 | 1 | PS | ENDOXAN ^BAXTER^ 1G - TROCKENSTECHAMPULLE | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 12142 | POWDER FOR SOLUTION FOR INJECTION | |||||||||
| 92726612 | 9272661 | 2 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | LOADING DOSE | U | 113410,113410,113410 | 0 | Q3W | |||||||
| 92726612 | 9272661 | 3 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 113410,113410,113410 | 0 | Q3W | ||||||||
| 92726612 | 9272661 | 4 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 113410,113410,113410 | 0 | Q3W | ||||||||
| 92726612 | 9272661 | 5 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | LOADING DOSE, INFUSION SOLUTION | U | 0 | 8 | MG/KG | Q3W | ||||||
| 92726612 | 9272661 | 6 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 6 MG/KG, MAINTENANCE DOSE, INFUSION SOLUTION | U | 0 | 600 | MG | Q3W | ||||||
| 92726612 | 9272661 | 7 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | U | 0 | ||||||||||
| 92726612 | 9272661 | 8 | SS | EPIRUBICIN HYDROCHLORIDE. | EPIRUBICIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 92726612 | 9272661 | 9 | C | PARICALCITOL. | PARICALCITOL | 1 | Unknown | 0 | 2 | DF | QD | ||||||||
| 92726612 | 9272661 | 10 | C | Euthyrox | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | 150 | UG | QD | ||||||||
| 92726612 | 9272661 | 11 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Unknown | 0 | 2 | DF | QD | ||||||||
| 92726612 | 9272661 | 12 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | 0 | 120 | MG | QD | ||||||||
| 92726612 | 9272661 | 13 | C | Feretab | 2 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92726612 | 9272661 | 1 | Breast cancer |
| 92726612 | 9272661 | 2 | Breast cancer |
| 92726612 | 9272661 | 5 | Breast cancer |
| 92726612 | 9272661 | 7 | Breast cancer |
| 92726612 | 9272661 | 8 | Breast cancer |
| 92726612 | 9272661 | 9 | Product used for unknown indication |
| 92726612 | 9272661 | 10 | Product used for unknown indication |
| 92726612 | 9272661 | 11 | Product used for unknown indication |
| 92726612 | 9272661 | 12 | Product used for unknown indication |
| 92726612 | 9272661 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92726612 | 9272661 | HO |
| 92726612 | 9272661 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92726612 | 9272661 | Cardiac failure | |
| 92726612 | 9272661 | Mitral valve incompetence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92726612 | 9272661 | 2 | 20130102 | 0 | ||
| 92726612 | 9272661 | 3 | 20130416 | 0 | ||
| 92726612 | 9272661 | 4 | 20130326 | 0 | ||
| 92726612 | 9272661 | 5 | 20130102 | 0 | ||
| 92726612 | 9272661 | 6 | 20130416 | 0 | ||
| 92726612 | 9272661 | 12 | 20130111 | 0 |